Intermittent fasting benefits adults but may harm young beta cells, increasing diabetes risk in adolescents. A recent study ...

A naturally occurring molecule that works as effectively as other semaglutide-based drugs — without the common side effects — ...

Early-life gut microbes could play a key role in protecting against diabetes. A healthy start for a healthier future.

The microbiome shapes development of insulin-producing cells in infancy, leading to long-term changes in metabolism and diabetes risk, new research in mice has found.

Murine study identifies critical neonatal window when microbiota disruption results in lifelong metabolic consequences stemming from reduced β cell development.

People on Ozempic and other GLP-1 agonist drugs commonly report they no longer have constant, incessant thoughts about food.

The results could ultimately help doctors reduce the risk of type 1 diabetes—or potentially even restore lost metabolic function in adulthood—by providing gut microbes that help the pancreas grow and ...

The microbiome shapes the development of insulin-producing cells in infancy, leading to long-term changes in metabolism and ...

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide - also known as Ozempic - in suppressing appetite and reducing body weight.

Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality. I n 2024, a woman ...

Researchers have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity - a harmful condition linked to the progression of type 2 ...